For the Inventor, By the Inventor

Enter assignee name

Troy, NY, United States of America

Virogenetics Corporation

USPTO Granted Patents = 34

% Expired Patents = 2.9

EPO Patents = 1

Forward Citations = 989

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Enzo Paoletti (34 out of 64 patents)

James Tartaglia (17 out of 32 patents)

William I Cox (15 out of 20 patents)

4. Jill Taylor (12 out of 16 patents)

5. Steven E Pincus (11 out of 13 patents)

6. Russell Robert Gettig (10 out of 12 patents)

7. Keith J Limbach (7 out of 7 patents)

8. Charles De Taisne (5 out of 7 patents)

9. Marion E Perkus (5 out of 5 patents)

10. Michel Albert Riviere (4 out of 23 patents)

11. Gerard P Johnson (4 out of 4 patents)

12. Elizabeth K Norton (4 out of 4 patents)

13. Jean-Christophe Francis Audonnet (4 out of 4 patents)

14. Hector Martinez (2 out of 2 patents)

15. Louis Ross (2 out of 2 patents)

Core Competencies:

Recombinant Poxvirus

Cytokine Genes

Tumor Associated Antigens

Expression Vectors

Vaccines

Canine Herpesvirus

Immunological Compositions

Flavivirus

Viral Recombination

Infectious Bursal Disease

Marek's Disease Virus

Modified Vaccinia Virus

34 patents: Sort by Forward Citations

1. 6632438 - Recombinant poxvirus cytomegalovirus, compositions, and uses (2003-10-14),

2. 6596279 - Immunodeficiency recombinant poxvirus (2003-07-22),

3. 6537594 - Vaccina virus comprising cytokine and/or tumor associated antigen genes (2003-03-25),

4. 6267965 - Recombinant poxvirus—cytomegalovirus compositions and uses (2001-07-31),

5. 6265189 - Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen (2001-07-24),

6. 6130066 - Vectors having enhanced expression and methods of making and uses thereof (2000-10-10),

7. 6017542 - Nucleotide and amino acid sequences of canine herpesvirus GD and uses (2000-01-25),

8. 6004777 - Vectors having enhanced expression, and methods of making and uses (1999-12-21),

9. 5990091 - Vectors having enhanced expression, and methods of making and uses (1999-11-23),

10. 5989561 - Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) (1999-11-23),

11. 5891442 - Infectious bursal disease virus recombination poxvirus vaccine (1999-04-06),

12. 5863542 - Recombinant attenuated ALVAC canaryopox virus containing heterologous (1999-01-26),

13. 5858373 - Recombinant poxvirus-feline infectious peritionitis virus, compositions (1999-01-12),

14. 5843456 - Alvac poxvirus-rabies compositions and combination compositions and uses (1998-12-01),

15. 5833975 - Canarypox virus expressing cytokine and/or tumor-associated antigen DNA (1998-11-10),

Company Overview

Virogenetics Corporation, based in Troy, NY, specializes in the development of innovative biopharmaceuticals and therapeutic solutions. The company focuses on harnessing advanced genetic engineering techniques to create treatments for various diseases, particularly in the field of infectious diseases and cancer. Virogenetics is dedicated to pioneering research that leverages cutting-edge technology to enhance patient outcomes and contribute to the evolving landscape of medical science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

34 Patents

#3 in Troy, NY

#601 in New York

#10,022 in US

#19,651 in the World

Troy, NY, United States of America

Virogenetics Corporation

Forward Citations = 989

25 inventors:

Enzo Paoletti (34 out of 64 patents)

James Tartaglia (17 out of 32 patents)

William I Cox (15 out of 20 patents)

4. Jill Taylor (12 out of 16 patents)

5. Steven E Pincus (11 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Virogenetics Corporation. Retrieved from https://idiyas.com/company/virogenetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…